Last Updated on September 2, 2024 by admin
Lagmitaf Tablet Overview
- Active ingredient –Tenofovir Alafenamide + Emtricitabine + Bictegravir
- Strength availability – 25mg + 200mg + 50mg
- Manufactured by – Hetero
- Package 30 Tablets
Lagmitaf is an anti-retroviral drug containing three prominent factors is known as; Tenofovir Alafenamide Emtricitabine Bictegravir Tenofovir Alafenamide is a nucleotide transcriptase inhibitor Emtricitabine is a nucleoside reverse transcriptase inhibitor Bictegravir is an integrase inhibitor.
These are the most effective & a potent compound against HIV-1 infections, but it does not cure the infection situation it is only used for preventing & suppressing the evolution of HIV-1 infection into AIDS. In Lagmitaf tablets, TAF is present as a prodrug. Emtricitabine is a synthetics fluoro derivative of thiacytodone. Bictegravir is an investigational drug.
Lagmitaf Tablet Medicinal Benefits
One of the key benefits of the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (Lagmitaf Tablet) is its effectiveness in suppressing the HIV-1 virus. It is known to reduce the viral load, increase CD4 cell count, and improve the overall immune system of individuals living with HIV-1 infection.
Lagmitaf Tablet Directions for Use
It is important to follow the prescribed dosage and directions provided by your healthcare professional. Typically, the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (Lagmitaf Tablet) is taken orally once daily with or without food. It is recommended to take it at the same time each day to ensure consistent levels of the medication in your body.
Lagmitaf Tablet Storage
Proper storage of the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (Lagmitaf Tablet) is crucial to maintain its effectiveness. It should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
Lagmitaf Tablet INDICATIONS
Lagmitaf is a combination tablet that contains Tenofovir Alafenamide, Emtricitabine & Bictegravir is mainly indicated for the treatment of HIV-1 infection in adult patients.
Lagmitaf TABLET DOSAGE
The prescribed dose of Lagmitaf is one tablet that should be given orally as day-to-day. Important points; before starting the treatment, the patient should be considered for the presence of hepatitis B infection or not.
Lagmitaf TABLET is a prescription medicine that is used to treat Human Immunodeficiency Virus-1 (HIV-1) in adults and children who weigh at least 25 kg.
Uses of Lagmitaf Tablet
How Lagmitaf Tablet works
Lagmitaf Tablet works by inhibiting the enzymes reverse transcriptase and integrase, thereby inhibiting the replication of viral particles in the body and treats the infection.
Interactions with other drugs:
Inform your doctor about any medications you are taking or have taken before the treatment.
Lagmitaf Tablet-Drug Warnings
Prior to starting the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (Lagmitaf Tablet), it is important to inform your healthcare professional about any existing medical conditions, allergies, or medications you are currently taking. They will be able to assess whether this medication is suitable for you and if any adjustments are necessary.
Lagmitaf Tablet Drug Interactions
The Tenofovir Alafenamide Emtricitabine Bictegravir tablet (Lagmitaf Tablet) may interact with certain medications, potentially affecting their effectiveness or increasing the risk of side effects. It is important to inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products.
Lagmitaf Tablet-Drug Interactions Checker List: Safety Advice
It is always advisable to consult your healthcare professional or use a reliable drug-drug interactions checker to ensure the safety and effectiveness of the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (Lagmitaf Tablet) when taken with other medications. This will help identify any potential interactions and allow your healthcare professional to make informed decisions regarding your treatment plan.
Lagmitaf Tablet-Habit Forming
The Tenofovir Alafenamide Emtricitabine Bictegravir tablet (Lagmitaf Tablet) is not habit-forming. It is a prescription medication that should be taken as directed by your healthcare professional.
SIDE EFFECTS OF Lagmitaf TABLET
- Common
- Insomnia (difficulty in sleeping)
- Headache
- Diarrhea
- Nausea
- Rash
- Abdominal pain
- Fatigue
- Cough
- Back pain
HOW TO USE Lagmitaf TABLET
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Lagmitaf Tablet may be taken with or without food, but it is better to take it at a fixed time.
SAFETY ADVICE
warnings
Alcohol CAUTION
Caution is advised when consuming alcohol with Lagmitaf Tablet. Please consult your doctor.
warnings
Pregnancy CAUTION
CONSULT YOUR DOCTOR
Lagmitaf Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
warnings
Breast feeding CAUTION
SAFE IF PRESCRIBED
Lagmitaf Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
warnings
Driving CAUTION
UNSAFE
Lagmitaf Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
warnings
Kidney CAUTION
SAFE IF PRESCRIBED
Lagmitaf Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Lagmitaf Tablet may not be needed in these patients. Please consult your doctor.
warnings
Liver CAUTION
SAFE IF PRESCRIBED
Lagmitaf Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Lagmitaf Tablet may not be needed in these patients. Please consult your doctor.
warnings
CHILDREN CAUTION
UNSAFE
Lagmitaf Tablet is not recommended for use in children and adolescents below 18 years.
Diet
There are no specific dietary restrictions associated with the Tenofovir Alafenamide Emtricitabine Bictegravir tablet (Lagmitaf Tablet). However, maintaining a healthy and balanced diet is always beneficial for overall health and wellbeing.
Expert Advice
WHAT IF YOU FORGET TO TAKE Lagmitaf TABLET?
A: If you miss a dose of Lagmitaf Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
- Lagmitaf Tablet is a combination of three medicines which slows down or stops the progression of HIV infections.
- Take it on an empty stomach, preferably at bedtime, to reduce side effects.
- Skipping doses increases the risk of treatment failure. Make sure that you take all your doses at the correct time.
- Lagmitaf Tablet may cause dizziness or sleepiness. Don’t drive or do anything requiring concentration until you know how it affects you.
- Lagmitaf Tablet can cause birth defects. Use effective contraception while taking Lagmitaf Tablet and 12 weeks after stopping it.
- It may cause weakening of your bones. Exercise regularly and take calcium and vitamin D supplements as suggested by your doctor.
- Your doctor may monitor your kidney and liver functions regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, darkened urine or yellowing of the eyes or skin.
- Do not stop taking Lagmitaf Tablet without your doctor’s advice.
- Keep Lagmitaf Tablet out of sight and reach of children.
Conclusion
The Tenofovir Alafenamide Emtricitabine Bictegravir tablet (Lagmitaf Tablet) is a valuable medication for the treatment of HIV-1 infection. It offers numerous medicinal benefits, including the suppression of the virus and improvement of the immune system. By following the prescribed dosage, storage guidelines, and consulting your healthcare professional regarding any potential drug interactions, you can effectively manage your condition and enhance your overall well-being.
Lagmitaf Tablet FAQs
Q: Is it safe to take Lagmitaf Tablet?
A: You should take Lagmitaf Tablet only as per your doctor’s advice.
Q: Can I get Lagmitaf Tablet without a prescription?
A: No, you need a doctor’s prescription to get Lagmitaf Tablet since it is a prescription medicine. Your doctor will prescribe it only if they judge that it would be beneficial for you.
Q: What Lagmitaf Tablet contains?
A: Lagmitaf Tablet contains salt composition of Bictegravir + Emtricitabine + Tenofovir Alafenamide (generic name).
Q: Who is the manufacturer of Lagmitaf Tablet?
A: Lagmitaf Tablet is manufactured/marketed by Hetero.
Q: How to use Lagmitaf Tablet?
A: Take this medicine in the dose and duration as advised by your doctor.
Q: what is the Lagmitaf tablets price?
A: The price of Lagmitaf tablet is cheaper if you buy it in bulk, the last rate of Lagmitaf tablet is available in @2999.You Can Order From HIVHUB.IN With Free Shipping Cash On Delivery Available No Hidden Charges.
Q: How/Where to buy Lagmitaf Tablet?
A: It is always better to check the credential of the person/distributor before confirming your order if you are importing medicine from India. As per the legal guidelines, only patients with a valid prescription or valid drug license holder can import the product after getting proper Documentation.
Some More Lagmitaf Tablet FAQs
1. What is Lagmitaf tablet used for?
Lagmitaf tablet is used for the treatment of HIV-1 infection in adults and children weighing at least 25 kg. It helps to control the virus and improve the immune system.
2. When is the best time to take Lagmitaf tablet?
Lagmitaf tablet can be taken at any time of the day, with or without food. It is important to take it consistently at the same time each day to maintain even levels of the medication in your body.
3. What are the long-term side effects of Lagmitaf tablet?
Long-term side effects may include liver problems, changes in body fat, and potential effects on kidney function. Regular monitoring by a healthcare provider is recommended.
4. Can you provide a review of Lagmitaf tablet?
Many patients report that Lagmitaf tablet is effective in managing their HIV with minimal side effects. However, individual experiences may vary, and it is important to consult a healthcare professional for personalized advice.
5. What are the common uses of Lagmitaf tablet?
The primary use of Lagmitaf tablet is to treat HIV-1 infection. It is also used in combination with other medications for patients with specific treatment needs.
6. What is the recommended dosage of Lagmitaf tablet?
The recommended dosage for adults and children over 25 kg is one tablet (50 mg/200 mg/25 mg) taken once daily.
7. Is Lagmitaf tablet safe to use?
Lagmitaf tablet is generally considered safe for most patients; however, it is important to discuss your medical history and any potential allergies with your healthcare provider before starting treatment.
8. Does Lagmitaf tablet cure HIV infection?
No, Lagmitaf tablet does not cure HIV infection. It helps to control the virus and manage the condition effectively, allowing individuals to live healthier lives.
9. Is Lagmitaf tablet safe in pregnancy?
Lagmitaf tablet is generally considered safe during pregnancy, but it is important to discuss the risks and benefits with your healthcare provider.
10. Can Lagmitaf tablet be used on children?
Yes, Lagmitaf tablet can be used in children who weigh at least 25 kg, under the supervision of a healthcare provider.
11. What if I miss a dose of Lagmitaf tablet?
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once.
12. Can I stop taking Lagmitaf tablet?
You should not stop taking Lagmitaf tablet without consulting your healthcare provider, as this could lead to drug resistance and worsening of your condition.
13. What are the uses of Lagmitaf tablet?
Lagmitaf tablet is used to treat HIV-1 infection, and it may also be used in specific cases of pre-exposure prophylaxis (PrEP) under medical guidance.
14. Are there alternative medications to Lagmitaf tablet?
Yes, there are several alternative medications for HIV treatment, including other antiretroviral drugs. Your healthcare provider can recommend alternatives based on your specific situation.
15. Can Lagmitaf tablet interact with other medications?
Yes, Lagmitaf tablet can interact with other medications. It is crucial to inform your healthcare provider about all the medications you are taking to avoid potential interactions.
16. How long does it take for Lagmitaf tablet to show results?
Most patients may start to see improvements in their viral load within a few weeks of starting Lagmitaf tablet, although individual responses can vary.
17. What precautions should be taken while using Lagmitaf tablet?
Patients should have regular check-ups to monitor liver function and kidney health, and should inform their doctor of any other health conditions and medications.
18. Where can I get more information about Lagmitaf tablet?
You can find more information about Lagmitaf tablet on the official website of the manufacturer, as well as from reputable health organizations like the CDC and WHO.
19. What is the success rate of Lagmitaf tablet in treating HIV?
Lagmitaf tablet has shown high efficacy rates in clinical trials, with many patients achieving viral suppression. However, individual results may vary based on adherence and other factors.
20. Can I find references for more detailed information?
Yes, you can refer to the following links for more detailed information:
– [FDA – Lagmitaf tablet Information] https://www.fda.gov
– [CDC – HIV Treatment Guidelines](https://www.cdc.gov/hiv/guidelines/index.html)
– [NIH – BIKTARVY (Lagmitaf tablet) Overview](https://aidsinfo.nih.gov)
Please consult your healthcare provider for personalized medical advice and recommendations.
References:
- KD Tripathi, Essentials of Medical Pharmacology, Antiviral drugs, 7th edition, 2013, 808.
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Antiretroviral agents and treatment of HIV infection, 12th edition, 2011, 1634-1638.
- Gilead Sciences Ltd, Electronic medicines compendium (emc), [ Revised on May 2021] [ Accessed on 11th Jan 2022], https://www.medicines.org.uk/emc/files/pil.9313.pdf
There are no reviews yet.